This inventor holds 2 USPTO granted patents. Top assignee: Schering Corporation. Active years: 2006-2010.
Company Filing History:
Years Active: 2006-2010
Title: The Innovative Contributions of Vilas A Dahanukar
Introduction
Vilas A Dahanukar is a notable inventor based in Edison, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of xanthine phosphodiesterase V inhibitors. With a total of 2 patents, his work has the potential to impact various therapeutic applications.
Latest Patents
Dahanukar's latest patents focus on a process for preparing xanthine phosphodiesterase V inhibitors and their precursors. This innovative process includes a five-step methodology for the efficient synthesis of Compound 5 without the need for intermediate purifications or separations. Additionally, it features a dihalogenation step to synthesize Compound 7, followed by a coupling reaction to produce Compound 9. These advancements highlight his commitment to improving pharmaceutical synthesis techniques.
Career Highlights
Vilas A Dahanukar is currently associated with Schering Corporation, where he continues to push the boundaries of pharmaceutical research. His expertise in the field has led to the development of novel compounds that may offer new treatment options for various medical conditions.
Collaborations
Throughout his career, Dahanukar has collaborated with talented individuals such as Hoa N Nguyen and Cecilia A Orr. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Vilas A Dahanukar's contributions to the field of pharmaceuticals through his patents and collaborations demonstrate his dedication to advancing medical science. His innovative processes for synthesizing xanthine phosphodiesterase V inhibitors are paving the way for future developments in therapeutic treatments.